Home » Newsletters » BioWorld Science

BioWorld Science

June 13, 1997

View Archived Issues

Inex: Q1 1997 highlights

ACE inhibitors for diabetes

GLP-1 and analogues studied for diabetes

rIGF-1 + insulin improves metabolic control in IDDM patients

Fibrinogen antagonists in IDDM

Results of D1/D2 receptor coactivation in diabetes

Favorable preclinical results with REPEL-CV for cardiovascular surgery

Combination insulin sensitizer + alpha-glucosidase inhibitor for diabetes

Carvedilol and its metabolite attenuate Hb-mediated neuronal injury

Gensia receives FDA approval of ANDA for atracurium besilate

KW-3902 may be beneficial in hemorrhagic shock

Testosterone transdermal patch now available in the U.S. in a once-daily formulation

Melatonin evaluated in emergency physicians on the night shift

D-0870 for AIDS-related oral candidiasis

Guilford granted U.S. patent for polymer drug delivery of anticancer agents

Activity of Sch-48973 against enteroviruses

AM-1155: in vitro and in vivo antichlamydial activity

Bay-12-8039: time-kill and PAE studies

Oral human immunoglobulin enters clinic for severe RA

IND for gene therapy for cystic fibrosis approved

Osiris and Activated Cell Therapy initiate MSC collaboration

Highlights from the 12th Annual ASH Scientific Meeting

Schering-Plough and Corvas sign hepatitis research collaboration

Neurogen reports promising phase I results with antiobesity drug

Banyu to shift development from NB-506 to new indolocarbazole

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Peptidream reveals milestone in Alnylam collaboration
BioWorld Science
Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...